Epstein Secrets

he FBI and Justice Department's intervention in the 2016 election. Barr Doesn't Rule Out Release Of Durham Report During Election. Politico (7/28, Gerstein, 4.29M) reports that a "highly anticipated forthcoming report from U.S. Attorney John Durham on the origins of the Trump-Russia investigation won't

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." UN

Release Of Durham Report During Election. Politico <https://www.politico.com/news/2020/07/28/barr-pre-election-release-durham-report-385244> (7/28, Gerstein, 4.29M) reports that a "highly anticipated forthcoming report from U.S. Attorney John Durham on the origins of the Trump-Russia investigation won't

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." UN

he FBI and Justice Department's intervention in the 2016 election. Barr Doesn't Rule Out Release Of Durham Report During Election. Politico (7/28, Gerstein, 4.29M) reports that a "highly anticipated forthcoming report from U.S. Attorney John Durham on the origins of the Trump-Russia investigation won't

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." U

he FBI and Justice Department's intervention in the 2016 election. Barr Doesn't Rule Out Release Of Durham Report During Election. Politico (7/28, Gerstein, 4.29M) reports that a "highly anticipated forthcoming report from U.S. Attorney John Durham on the origins of the Trump-Russia investigation won't

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." U